Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04879823 · ClinicalTrials.gov registry record · Phase 3
Post-operative Course of Dexamethasone to Reduce Tonsillectomy Morbidity
A Phase 3 study, sponsored by David Chi, MD.
- Terminated
- Registry status
- Phase 3
- Development phase
- 222
- Enrollment target
NCT04879823 is a Phase 3 study that was terminated before completion, run by David Chi, MD. The registered enrollment target is 222 participants.
The verdict
NCT04879823, a Phase 3 study, was terminated before completion, sponsored by David Chi, MD.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 222 participants
- Enrollment target
Study Summary
The goal of this study is determine if an oral systemic course of steroids is a safe and effective option in lowering pain and complications following adenotonsillectomy in various pediatric age groups. A double blind, placebo-controlled randomized clinical trial of steroids (dexamethasone) versus placebo postoperatively will be performed. Investigators will determine if there is a difference in post-operative pain and complications between groups.
Interventions
- DRUG Placebo
- DRUG Acetaminophen
- DRUG Ibuprofen
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2021-08-05 |
| Est. Completion | 2023-07-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04879823
The ClinicalTrials.gov registry entry for NCT04879823 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 222 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David Chi, MD, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT04879823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04879823 about?
NCT04879823 is a clinical study titled "Post-operative Course of Dexamethasone to Reduce Tonsillectomy Morbidity". The goal of this study is determine if an oral systemic course of steroids is a safe and effective option in lowering pain and complications following adenotonsillectomy in various pediatric age groups. A double blind, placebo-controlled randomized clinical trial of steroids (dexamethasone) versus p...
What is the current status of trial NCT04879823?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 222 participants. The study started on 2021-08-05. Estimated completion is 2023-07-11.
What interventions are being tested in trial NCT04879823?
The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG), Ibuprofen (DRUG), Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT04879823?
This trial is sponsored by David Chi, MD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.